Ronald M. MD Kurtz - Dec 27, 2023 Form 4 Insider Report for RxSight, Inc. (RXST)

Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol
RXST
Transactions as of
Dec 27, 2023
Transactions value $
-$924,498
Form type
4
Date filed
12/29/2023, 04:57 PM
Previous filing
Dec 18, 2023
Next filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Sale -$924K -22.5K -2.53% $41.09 867K Dec 27, 2023 See footnote F1, F2, F3
holding RXST Common Stock 40K Dec 27, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
F2 Represents the weighted average share price of an aggregate total of 22,500 shares sold in the price range of $41.00 to $41.2875 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.

Remarks:

President & Chief Executive Officer